Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets close in 2 hours 48 minutes

S&P 500
5,972.42
+23.71(+0.40%)
Dow 30
44,241.86
+371.51(+0.85%)
Nasdaq
19,022.53
+50.11(+0.26%)
Russell 2000
2,402.44
+38.42(+1.63%)
Crude Oil
71.29
+1.19(+1.70%)
Gold
2,709.70
+34.80(+1.30%)

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

372.92

+5.56

(+1.51%)

As of 01:11PM EST. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	16.40B
Enterprise Value	13.47B
Trailing P/E	16.14
Forward P/E	13.46
PEG Ratio (5 yr expected)	1.58
Price/Sales (ttm)	6.51
Price/Book (mrq)	2.69
Enterprise Value/Revenue	4.89
Enterprise Value/EBITDA	8.67

Trading Information

Stock Price History

Beta (5Y Monthly)	0.56
52-Week Change ³	58.94%
S&P500 52-Week Change ³	30.47%
52 Week High ³	417.82
52 Week Low ³	208.62
50-Day Moving Average ³	364.39
200-Day Moving Average ³	301.70

Share Statistics

Avg Vol (3 month) ³	357.6k
Avg Vol (10 day) ³	355.41k
Shares Outstanding ⁵	44.64M
Implied Shares Outstanding ⁶	44.64M
Float ⁸	40.93M
% Held by Insiders ¹	1.84%
% Held by Institutions ¹	100.87%
Shares Short (Oct 31, 2024) ⁴	2.3M
Short Ratio (Oct 31, 2024) ⁴	7.51
Short % of Float (Oct 31, 2024) ⁴	6.79%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	5.16%
Shares Short (prior month Sep 30, 2024) ⁴	2.24M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	2:1
Last Split Date ³	Sep 23, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	40.31%
Operating Margin (ttm)	54.51%

Management Effectiveness

Return on Assets (ttm)	11.89%
Return on Equity (ttm)	18.81%

Income Statement

Revenue (ttm)	2.76B
Revenue Per Share (ttm)	60.24
Quarterly Revenue Growth (yoy)	22.90%
Gross Profit (ttm)	N/A
EBITDA	1.41B
Net Income Avi to Common (ttm)	1.11B
Diluted EPS (ttm)	22.78
Quarterly Earnings Growth (yoy)	15.50%

Balance Sheet

Total Cash (mrq)	3.33B
Total Cash Per Share (mrq)	74.51
Total Debt (mrq)	400M
Total Debt/Equity (mrq)	6.56%
Current Ratio (mrq)	4.58
Book Value Per Share (mrq)	136.74

Cash Flow Statement

Operating Cash Flow (ttm)	1.14B
Levered Free Cash Flow (ttm)	710.09M